Defining a functionally distinct subset of human memory CD4+ T cells that are CD25POS and FOXP3NEG

被引:39
作者
Triplett, Todd A. [1 ,2 ]
Curti, Brendan D. [1 ]
Bonafede, Peter R. [3 ]
Miller, William L. [1 ]
Walker, Edwin B. [1 ]
Weinberg, Andrew D. [1 ,2 ]
机构
[1] Providence Portland Med Ctr, Robert W Franz Canc Res Ctr, Earle A Chiles Res Inst, Portland, OR 97213 USA
[2] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA
[3] Providence Portland Med Ctr, Providence Arthrit Ctr, Portland, OR 97213 USA
关键词
CD4; CD25; Co-stimulation; IL-2; Immunotherapy; RECEPTOR-ALPHA-CHAIN; AUTOIMMUNE-DISEASE; IN-VITRO; EXPRESSION; INTERLEUKIN-2; EFFECTOR; CD25; LYMPHOCYTES; TRANSCRIPTION; ENDOCYTOSIS;
D O I
10.1002/eji.201242444
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Surface expression of the IL-2 receptor a-chain (CD25) has been used to discriminate between CD4+CD25HIFOXP3+ regulatory T (Treg) cells and CD4+CD25NEGFOXP3- non-Treg cells. However, this study reports that the majority of resting human memory CD4+FOXP3- T cells expresses intermediate levels of CD25 and that CD25 expression can be used to delineate a functionally distinct memory subpopulation. The CD25NEG memory T-cell population contains the vast majority of late differentiated cells that respond to antigens associated with chronic immune responses and are increased in patients with systemic lupus erythematosus (SLE). In contrast, the CD25INT memory T cells respond to antigens associated with recall responses, produce a greater array of cytokines, and are less dependent on costimulation for effector responses due to their expression of CD25. Lastly, compared to the CD25NEG and Treg-cell populations, the CD25INT memory population is lost to a greater degree from the blood of cancer patients treated with IL-2. Collectively, these results show that in humans, a large proportion of CD4+ memory T cells express intermediate levels of CD25, and this CD25INTFOXP3- subset is a functionally distinct memory population that is uniquely affected by IL-2.
引用
收藏
页码:1893 / 1905
页数:13
相关论文
共 54 条
[41]  
STEIGER J, 1995, J IMMUNOL, V155, P489
[42]   CD4+CD28null T cells in autoimmune disease:: Pathogenic features and decreased susceptibility to immunoregulation [J].
Thewissen, Marielle ;
Somers, Veerle ;
Hellings, Niels ;
Fraussen, Judith ;
Damoiseaux, Jan ;
Stinissen, Piet .
JOURNAL OF IMMUNOLOGY, 2007, 179 (10) :6514-6523
[43]   CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production [J].
Thornton, AM ;
Shevach, EM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (02) :287-296
[44]  
UCHIYAMA T, 1981, J IMMUNOL, V126, P1393
[45]   Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection [J].
van Leeuwen, EMM ;
Remmerswaal, EBM ;
Vossen, MTM ;
Rowshani, AT ;
Wertheim-van Dillen, PME ;
van Lier, RAW ;
ten Berge, IJM .
JOURNAL OF IMMUNOLOGY, 2004, 173 (03) :1834-1841
[46]   Impact of Basiliximab on regulatory T-cells early after kidney transplantation: down-regulation of CD25 by receptor modulation [J].
Vondran, Florian Wolfgang Rudolf ;
Timrott, Kai ;
Tross, Janice ;
Kollrich, Sonja ;
Schwarz, Anke ;
Lehner, Frank ;
Klempnauer, Juergen ;
Becker, Thomas ;
Schwinzer, Reinhard .
TRANSPLANT INTERNATIONAL, 2010, 23 (05) :514-523
[47]   Short-term anti-CD25 monoclonal antibody administration down-regulated CD25 expression without eliminating the neogenetic functional regulatory T cells in kidney transplantation [J].
Wang, Z. ;
Shi, B. -Y. ;
Qian, Y. -Y. ;
Cai, M. ;
Wang, Q. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2009, 155 (03) :496-503
[48]   Striking alteration of some populations of T/B cells in systemic lupus erythematosus: relationship to expression of CD62L or some chemokine receptors [J].
Watanabe, T. ;
Suzuki, J. ;
Mitsuo, A. ;
Nakano, S. ;
Tamayama, Y. ;
Katagiri, A. ;
Amano, H. ;
Morimoto, S. ;
Tokano, Y. ;
Takasaki, Y. .
LUPUS, 2008, 17 (01) :26-33
[49]   INTERLEUKIN-2 RECEPTOR-ALPHA CHAIN REGULATES THE SIZE AND CONTENT OF THE PERIPHERAL LYMPHOID COMPARTMENT [J].
WILLERFORD, DM ;
CHEN, JZ ;
FERRY, JA ;
DAVIDSON, L ;
MA, A ;
ALT, FW .
IMMUNITY, 1995, 3 (04) :521-530
[50]   A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy [J].
Wuest, Simone C. ;
Edwan, Jehad H. ;
Martin, Jayne F. ;
Han, Sungpil ;
Perry, Justin S. A. ;
Cartagena, Casandra M. ;
Matsuura, Eiji ;
Maric, Dragan ;
Waldmann, Thomas A. ;
Bielekova, Bibiana .
NATURE MEDICINE, 2011, 17 (05) :604-U125